Abstract
The purpose of the current research is to synthesize radiolabeled rutin for biodistribution study and SPECT/CT image of rutin. The optimized radiolabeling condition provided 125I-labeled rutin with 53.5 % of radiochemical yield. Most of orally administered 125I-labeled rutin was initially found in the stomach and small intestine and a portion of the product was then distributed in internal organs. While intravenously injected 125I-labeled rutin was accumulated in liver and then a large part of it was transferred to small intestine. The present results provided an efficient radiolabeling method of flavonoid glycoside as well as quantitative organ distribution of rutin.
| Original language | English |
|---|---|
| Pages (from-to) | 477-483 |
| Number of pages | 7 |
| Journal | Journal of Radioanalytical and Nuclear Chemistry |
| Volume | 308 |
| Issue number | 2 |
| DOIs | |
| State | Published - 1 May 2016 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- I
- Biodistribution
- Radiolabeling
- Rutin
- SPECT/CT
Fingerprint
Dive into the research topics of 'Efficient radiolabeling of rutin with 125I and biodistribution study of radiolabeled rutin'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver